Featured Press Releases

ENHERTU® Plus Pertuzumab Significantly Improves Progression-Free Survival vs. THP in 1st-Line Treatment for HER2+ Metastatic Breast Cancer

ENHERTU® Plus Pertuzumab Significantly Improves Progression-Free Survival vs. THP in 1st-Line Treatment for HER2+ Metastatic Breast Cancer

Space Cargo Unlimited and Exobiosphere Partner for High-Throughput Space Biotech

Space Cargo Unlimited and Exobiosphere Partner for High-Throughput Space Biotech

  • 17 Jun 2025

Exobiosphere S.à r.l. and Space Cargo Unlimited today announced the signing of a Memorandum of...

Apotex Corp. Introduces Generic Fertility Treatment Injectable Cetrorelix® in the United States

Apotex Corp. Introduces Generic Fertility Treatment Injectable Cetrorelix® in the United States

NLS Pharmaceutics and Kadimastem announce a $500,000 initial closing of a $1 million fundraising, with shares priced at $3.10, a 48% premium over the January 6, 2025 market price

NLS Pharmaceutics and Kadimastem announce a $500,000 initial closing of a $1 million fundraising, with shares priced at $3.10, a 48% premium over the January 6, 2025 market price

The European Commission grants Aurobindo Pharma approval to market the cancer drug, Dazublys

The European Commission grants Aurobindo Pharma approval to market the cancer drug, Dazublys

BEACON Real-World Study Shows Positive Top-Line Results for ZUNVEYL® in Alzheimer’s Disease, Reports Alpha Cognition

BEACON Real-World Study Shows Positive Top-Line Results for ZUNVEYL® in Alzheimer’s Disease, Reports Alpha Cognition

BioMarin

BioMarin's Supplemental New Drug Application for Full Approval of VOXZOGO® (vosoritide) for Children With Achondroplasia Accepted by the U.S. Food and Drug Administration

  • BioMarin Pharmaceutical Inc.
  • 13 Jul 2026
FDA Approves Expanded Indication for Octapharma USA

FDA Approves Expanded Indication for Octapharma USA's wilate® for Prophylaxis of von Willebrand Disease in Children Younger Than 6 Years

  • Octapharma
  • 10 Jul 2026
Industry Veteran Marie Emms Appointed President of Clinical Business at Spectrum Science

Industry Veteran Marie Emms Appointed President of Clinical Business at Spectrum Science

  • Spectrum Science
  • 08 Jul 2026
Cannabix Technologies and Omega Laboratories Announce a DOT-Like Breath-Based Drug Testing Panel for Recent-Use Detection

Cannabix Technologies and Omega Laboratories Announce a DOT-Like Breath-Based Drug Testing Panel for Recent-Use Detection

  • Omega Laboratories, Inc.
  • 08 Jul 2026
Organon to Present New Analysis of VTAMA® (tapinarof) Cream, 1%

Organon to Present New Analysis of VTAMA® (tapinarof) Cream, 1%

  • Organon
  • 07 Jul 2026
European Commission Approves AbbVie

European Commission Approves AbbVie's TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • AbbVie
  • 06 Jul 2026
The Digital Pharma Advances Conference 2026

Most Popular
July   2026
M T W T F S S
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.